1. Mortalité trois mois après transplantation hépatique : étude monocentrique sur une période de vingt ans
- Author
-
Jung, B., Cisse, M., Chanques, G., Arsac, E., Bismuth, M., Panaro, F., Perrigault, P.-F., Souche, B., Gallix, B., Verzilli, D., Delay, J.-M., Navarro, F., Pageaux, G.-P., and Jaber, S.
- Subjects
- *
LIVER transplantation , *SURGICAL complications , *MORTALITY , *RETROSPECTIVE studies , *CIRRHOSIS of the liver , *HEPATITIS C , *LIVER cancer , *SEPTICEMIA prevention , *HEMORRHAGE prevention , *IMMUNOSUPPRESSION - Abstract
Abstract: Objective: To define the causes of mortality of patients who died within the first three months after a liver transplantation. Type of study: Retrospective, observational, and single centre study. Patients and methods: Between March 1989 and July 2010, all patients who died within three months after a liver transplantation were included. Demographic characteristics, preoperative and peroperative data, donor characteristics, postoperative complications and causes of mortality were collected. Results: Among the 788 performed liver transplantations, 76 patients died in intensive care unit (11%). The main indications of liver transplantation were alcoholic cirrhosis (30%), hepatitis C (28%), hepatocarcinoma (15%), primitive or secondary biliary cirrhosis (10%). Fifty percent of the patients were categorized as Child C. The main causes of death were non-function or dysfunction with retransplantation contra-indication graft (18%), sepsis (18%), neurological complications (12%), hemorrhagic shock (13%), (9%), multiorgan failures (5%), cardiac complications (6%). Conclusion: In this study, the main causes of mortality were infectious, neurological and hemorrhagic. These results emphasize the necessity for better control of sepsis, haemorrhage and immunosupressors. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF